New drug tested to ease debilitating endometriosis pain
NCT ID NCT05101317
Summary
This study tested whether an investigational drug called HMI-115 could safely reduce pain in women with moderate to severe endometriosis. For 12 weeks, 142 participants received either the drug or a placebo (inactive substance) to compare their pain levels. The main goal was to see if HMI-115 was more effective than the placebo at easing menstrual and pelvic pain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Instytut Matki i Dziecka
Warsaw, Masovian Voivodeship, Poland
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100703, China
-
Physicians' Research Options, LLC- Corner Canyon Clinic
Draper, Utah, 84020, United States
-
Specjalistyczna Poradnia Ginekologiczna Gabinet Ginekologiczny Dr med. Janusza Tomaszewskiego
Bialystok, Podlaskie Voivodeship, Poland
-
Tidewater Clinical Research/TPW
Norfolk, Virginia, 23502, United States
Conditions
Explore the condition pages connected to this study.